Pavel Golubchik

Summary

Country: Israel

Publications

  1. doi request reprint Reboxetine treatment for autistic spectrum disorder of pediatric patients with depressive and inattentive/hyperactive symptoms: an open-label trial
    Pavel Golubchik
    Child and Adolescent Outpatient Clinic, Geha Mental Health Center, Petah Tikva, Israel
    Clin Neuropharmacol 36:37-41. 2013
  2. doi request reprint Handshaking as a measure of social responsiveness in patients with autistic spectrum disorder
    Pavel Golubchik
    Child and Adolescent Outpatient Clinic, Geha Mental Health Center, Petah Tikva 49100, Israel
    Compr Psychiatry 53:805-8. 2012
  3. doi request reprint Low-dose quetiapine for adolescents with autistic spectrum disorder and aggressive behavior: open-label trial
    Pavel Golubchik
    Geha Mental Health Center, Petah Tikva, Israel
    Clin Neuropharmacol 34:216-9. 2011
  4. ncbi request reprint Influence of methylphenidate treatment on smoking behavior in adolescent girls with attention-deficit/hyperactivity and borderline personality disorders
    Pavel Golubchik
    Geha Mental Health Center, Petah Tikva, Israel
    Clin Neuropharmacol 32:239-42. 2009
  5. doi request reprint Platelet poor plasma serotonin level in delinquent adolescents diagnosed with conduct disorder
    Pavel Golubchik
    Geha Mental Health Center, Petah Tikva, Israel
    Prog Neuropsychopharmacol Biol Psychiatry 33:1223-5. 2009
  6. doi request reprint Neurosteroid blood levels in delinquent adolescent boys with conduct disorder
    Pavel Golubchik
    Geha Mental Health Center, Petah Tikva, Israel Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Eur Neuropsychopharmacol 19:49-52. 2009
  7. ncbi request reprint Methylphenidate in the treatment of female adolescents with cooccurrence of attention deficit/hyperactivity disorder and borderline personality disorder: a preliminary open-label trial
    Pavel Golubchik
    Child and Adolescent Outpatient Clinic, Geha Mental Health Center, Petah Tiqva, Israel
    Int Clin Psychopharmacol 23:228-31. 2008
  8. doi request reprint Methylphenidate treatment in pediatric patients with attention-deficit/hyperactivity disorder and comorbid trichotillomania: a preliminary report
    Pavel Golubchik
    Child and Adolescent Outpatient Clinic, Geha Mental Health Center, Petah Tikva, Israel
    Clin Neuropharmacol 34:108-10. 2011
  9. ncbi request reprint Low platelet-poor plasma levels of serotonin in adult autistic patients
    Baruch Spivak
    Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Neuropsychobiology 50:157-60. 2004
  10. ncbi request reprint Neurosteroids in child and adolescent psychopathology
    Pavel Golubchik
    Child and Adolescent Outpatient Unit, Geha Mental Health Center, Petah Tiqva, Israel
    Eur Neuropsychopharmacol 17:157-64. 2007

Collaborators

Detail Information

Publications16

  1. doi request reprint Reboxetine treatment for autistic spectrum disorder of pediatric patients with depressive and inattentive/hyperactive symptoms: an open-label trial
    Pavel Golubchik
    Child and Adolescent Outpatient Clinic, Geha Mental Health Center, Petah Tikva, Israel
    Clin Neuropharmacol 36:37-41. 2013
    ..Both are often comorbid with autistic spectrum disorder (ASD). We evaluated the effectiveness of reboxetine treatment in pediatric patients with ASD with symptoms of depression and ADHD...
  2. doi request reprint Handshaking as a measure of social responsiveness in patients with autistic spectrum disorder
    Pavel Golubchik
    Child and Adolescent Outpatient Clinic, Geha Mental Health Center, Petah Tikva 49100, Israel
    Compr Psychiatry 53:805-8. 2012
    ..Unlike eye contact or complex social behavior, this gesture has not been studied in the past. We developed a rating scale intended to evaluate social responsiveness through handshaking, in patients with ASD...
  3. doi request reprint Low-dose quetiapine for adolescents with autistic spectrum disorder and aggressive behavior: open-label trial
    Pavel Golubchik
    Geha Mental Health Center, Petah Tikva, Israel
    Clin Neuropharmacol 34:216-9. 2011
    ..Atypical antipsychotics may be useful in treating aggression associated with autistic spectrum disorder (ASD). We evaluated the effectiveness of low-dose quetiapine treatment in ASD adolescent patients with aggressive behavior...
  4. ncbi request reprint Influence of methylphenidate treatment on smoking behavior in adolescent girls with attention-deficit/hyperactivity and borderline personality disorders
    Pavel Golubchik
    Geha Mental Health Center, Petah Tikva, Israel
    Clin Neuropharmacol 32:239-42. 2009
    ..We assessed the impact of methylphenidate (MPH)treatment on the smoking behavior of adolescent girls with ADHD/borderline personality disorder (BPD)...
  5. doi request reprint Platelet poor plasma serotonin level in delinquent adolescents diagnosed with conduct disorder
    Pavel Golubchik
    Geha Mental Health Center, Petah Tikva, Israel
    Prog Neuropsychopharmacol Biol Psychiatry 33:1223-5. 2009
    ..The aim of this study was to examine the platelet-poor plasma (PPP) serotonin (5-HT) levels among delinquent adolescent boys with conduct disorder (CD) in comparison with normal controls...
  6. doi request reprint Neurosteroid blood levels in delinquent adolescent boys with conduct disorder
    Pavel Golubchik
    Geha Mental Health Center, Petah Tikva, Israel Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Eur Neuropsychopharmacol 19:49-52. 2009
    ..054). DHEA and cortisol levels did not differ between the two groups. The interaction between neurosteroids ( especial DHEA-S) and genetic, developmental and environmental factors in juvenile delinquency merits further investigation...
  7. ncbi request reprint Methylphenidate in the treatment of female adolescents with cooccurrence of attention deficit/hyperactivity disorder and borderline personality disorder: a preliminary open-label trial
    Pavel Golubchik
    Child and Adolescent Outpatient Clinic, Geha Mental Health Center, Petah Tiqva, Israel
    Int Clin Psychopharmacol 23:228-31. 2008
    ..5+/-1.3 vs. 1.8+/-0.5, P<0.001). MPH was well tolerated. MPH may be useful and well tolerated in treating some shared symptoms of ADHD and BPD among female adolescents. Controlled studies are needed to substantiate these findings...
  8. doi request reprint Methylphenidate treatment in pediatric patients with attention-deficit/hyperactivity disorder and comorbid trichotillomania: a preliminary report
    Pavel Golubchik
    Child and Adolescent Outpatient Clinic, Geha Mental Health Center, Petah Tikva, Israel
    Clin Neuropharmacol 34:108-10. 2011
    ..This study aimed to assess the efficacy and tolerability of methylphenidate (MPH) treatment in children and adolescents who met the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, criteria for both ADHD and TTM...
  9. ncbi request reprint Low platelet-poor plasma levels of serotonin in adult autistic patients
    Baruch Spivak
    Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Neuropsychobiology 50:157-60. 2004
    ..The aim of this study was to determine 5-HT levels in platelet-poor plasma (PPP) in a group of adult patients with autism...
  10. ncbi request reprint Neurosteroids in child and adolescent psychopathology
    Pavel Golubchik
    Child and Adolescent Outpatient Unit, Geha Mental Health Center, Petah Tiqva, Israel
    Eur Neuropsychopharmacol 17:157-64. 2007
    ..The complex interaction between neurosteroids, neurodevelopment, life-events, genetics and mental disorders in children and adolescents merits further investigation...
  11. doi request reprint Attention-deficit/hyperactivity disorder and comorbid subsyndromal depression: what is the impact of methylphenidate on mood?
    Pavel Golubchik
    Child and Adolescent Outpatient Clinic, Geha Mental Health Center, Petah Tikva, Israel Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel Maccabi Health Services, Shfela Mental Health Division, Rishon Letzion, Israel Department of Community Mental Health, Haifa University, Haifa, Israel Research Unit, Geha Mental Health Center, Petah Tikva, Israel and Felsenstein Medical Research Center, Sackler Faculty of Medicine, Tel Aviv University, Petah Tikva, Israel
    Clin Neuropharmacol 36:141-5. 2013
    ..We assessed the effectiveness of methylphenidate (MPH) on both ADHD and mood symptoms in children and adolescents diagnosed with ADHD and coexistent subsyndromal depression (SSD)...
  12. ncbi request reprint The platelet-poor plasma 5-HT response to carbohydrate rich meal administration in adult autistic patients compared with normal controls
    Yaffa Vered
    Laboratory of Clinical Biochemistry, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
    Hum Psychopharmacol 18:395-9. 2003
    ..Our results indicate that in adult autistic patients, the pattern of PPP 5-HT responsivity to a dietary challenge of CRMT is dysregulated compared with normal controls and provide further support for the role of 5-HT in autism...
  13. ncbi request reprint [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)]
    Pavel Golubchik
    Geha Mental Health Center, Petah Tikva, Israel
    Harefuah 150:788-90, 814. 2011
    ..Methylphenidate treatment is recommended in cases when ADHD diagnosis was confirmed. Follow-up is required with special attention to possible cardiovascular, psychiatric and abusive side effects...
  14. ncbi request reprint The factors influencing decision making on children's psychiatric hospitalization: a retrospective chart review
    Pavel Golubchik
    Child and Adolescent Outpatient Clinic, Geha Mental HealthCenter, PO Box 102, 49100 Petah Tikva, Israel
    Community Ment Health J 49:73-8. 2013
    ..This is the first study,demonstrating a strong association between parental-capacity components and the rate of hospitalization...
  15. ncbi request reprint Methylphenidate treatment in children with attention deficit hyperactivity disorder and comorbid social phobia
    Pavel Golubchik
    aChild and Adolescent Outpatient Clinic bResearch Unit, Geha Mental Health Center cFelsenstein Medical Research Center, Sackler Faculty of Medicine, Tel Aviv University, Petah Tikva dSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Int Clin Psychopharmacol 29:212-5. 2014
    ..038), especially in school-related SP. The improvement in ADHD symptoms because of MPH treatment correlates with a parallel improvement in SP. MPH treatment appears to be safe and effective in ADHD/SP children. ..
  16. doi request reprint Predictors of stress-related growth in parents of children with ADHD
    Ricky Finzi-Dottan
    Bar Ilan University, School of Social Work, Ramat Gan 52900, Israel Child and Adolescence Outpatient Clinic, Geha Mental Health Center, Petah Tiqva, P O Box 102, 49100, Israel
    Res Dev Disabil 32:510-9. 2011
    ..Path analysis confirmed our research model, suggesting that parents' sense of competence and of parenthood as a challenge vs. a threat mediates between emotional intelligence and social support on the one hand, and growth on the other...